Журнал BMJ - Клинические испытания вакцины от коронавируса производства Pfizer, несмотря на отчеты компании о невероятной эффективности препарата, шли с нарушениями правил проведения подобных испытаний.

Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial | The BMJ

Revelations of poor practices at a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial raise questions about data integrity and regulatory oversight.

In recent months Jackson has reconnected with several former Ventavia employees who all left or were fired from the company. One of them was one of the officials who had taken part in the late September meeting. In a text message sent in June the former official apologised, saying that “everything that you complained about was spot on.”

Two former Ventavia employees spoke to The BMJ anonymously for fear of reprisal and loss of job prospects in the tightly knit research community. Both confirmed broad aspects of Jackson’s complaint. One said that she had worked on over four dozen clinical trials in her career, including many large trials, but had never experienced such a “helter skelter” work environment as with Ventavia on Pfizer’s trial.